tag Antibody
tag Antibody
 HA-Tag Polyclonal Tag Antibody |
|||
| A26004 | EpiGentek | 50 µg | Ask for price |
 TAG-72 Antibody |
|||
| P1023-01m | SAB | 0.1m | 224.4 EUR |
TAG-72 Antibody |
|||
| P1023-1ml | SAB | 1ml | 406.8 EUR |
TAG-72 Antibody |
|||
| V3178-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V3178-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V3178IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V3178SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9013-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a Tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9013-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a Tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9013IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a Tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9013SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a Tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9014-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9014-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9014IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V9014SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This mAb defines the mucin-carried sialylated-Tn epitope. TAG72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7058-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 antibody with a GCDFP-15 antibody is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7058-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 antibody with a GCDFP-15 antibody is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7058SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 antibody with a GCDFP-15 antibody is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2361-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 Ab with a GCDFP-15 Ab is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2361-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 Ab with a GCDFP-15 Ab is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2361IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 Ab with a GCDFP-15 Ab is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2361SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 Ab with a GCDFP-15 Ab is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2363-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 antibody with a GCDFP-15 antibody is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2363-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 antibody with a GCDFP-15 antibody is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2363IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 antibody with a GCDFP-15 antibody is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V2363SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 antibody with a GCDFP-15 antibody is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7718-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 Ab with a GCDFP-15 Ab is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7718-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 Ab with a GCDFP-15 Ab is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7718SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: This antibody recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. This antibody defines the mucin-carried sialylated-Tn epitope. TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of TAG-72 Ab with a GCDFP-15 Ab is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7779-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7779-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V7779SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: TAG-72 is usually expressed by adenocarcinomas, but is negative in mesotheliomas. Studies have reported that this antibody has 80% sensitivity and 93% specificity for pulmonary adenocarcinoma. Therefore, TAG-72 is a useful marker to distinguish between mesothelioma and adenocarcinoma. However, false positive reactions can occur so results must be interpreted with the utmost caution. This antibody may be useful in the differentiation of non-small cell carcinomas from small cell carcinomas of the lung. The combined use of anti-TAG-72 and anti-GCDFP-15 is valuable in the diagnosis of apocrine carcinoma. |
|||
TAG-72 Antibody |
|||
| V8841-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. The majority of human adenocarcinomas including colorectal, pancreatic, gastric, ovarian, endometrial, mammary, and non-small cell lung cancer display some cell populations that are positive for TAG72. About 60% of carcinoma patients express TAG72 in their sera. TAG72 is reportedly useful in distinguishing pulmonary adenocarcinomas from pleural mesotheliomas. |
|||
TAG-72 Antibody |
|||
| V8841-20UG | NSJ Bioreagents | 20ug | 153.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. The majority of human adenocarcinomas including colorectal, pancreatic, gastric, ovarian, endometrial, mammary, and non-small cell lung cancer display some cell populations that are positive for TAG72. About 60% of carcinoma patients express TAG72 in their sera. TAG72 is reportedly useful in distinguishing pulmonary adenocarcinomas from pleural mesotheliomas. |
|||
TAG-72 Antibody |
|||
| V8841SAF-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
|
Description: Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. The majority of human adenocarcinomas including colorectal, pancreatic, gastric, ovarian, endometrial, mammary, and non-small cell lung cancer display some cell populations that are positive for TAG72. About 60% of carcinoma patients express TAG72 in their sera. TAG72 is reportedly useful in distinguishing pulmonary adenocarcinomas from pleural mesotheliomas. |
|||
 HA Tag Antibody |
|||
| abx233742-100ug | Abbexa | 100 ug | 577.2 EUR |
 S1 tag Antibody |
|||
| abx237549-100ug | Abbexa | 100 ug | 661.2 EUR |
 HA Tag antibody |
|||
| 10R-10266 | Fitzgerald | 100 ug | 301.2 EUR |
|
Description: Mouse monoclonal HA Tag antibody |
|||
 E Tag antibody |
|||
| 10R-10458 | Fitzgerald | 100 ug | 522 EUR |
|
Description: Mouse monoclonal E Tag antibody |
|||
HA Tag antibody |
|||
| 10R-2935 | Fitzgerald | 100 ug | 418.8 EUR |
|
Description: Mouse monoclonal HA antibody |
|||
 V5 Tag antibody |
|||
| 10R-2939 | Fitzgerald | 100 ug | 204 EUR |
|
Description: Mouse monoclonal V5 Tag antibody |
|||
HA Tag antibody |
|||
| 10R-6754 | Fitzgerald | 200 ug | 859.2 EUR |
|
Description: Mouse monoclonal HA Tag antibody |
|||
V5 Tag antibody |
|||
| 10R-7558 | Fitzgerald | 100 ug | 318 EUR |
|
Description: Mouse monoclonal V5 tag antibody |
|||
HA Tag antibody |
|||
| 10R-7798 | Fitzgerald | 100 ug | 678 EUR |
|
Description: Mouse monoclonal HA Tag antibody |
|||
 HA tag antibody |
|||
| 10R-8050 | Fitzgerald | 200 ug | 589.2 EUR |
|
Description: Mouse monoclonal HA tag antibody |
|||
HA tag antibody |
|||
| 10R-8404 | Fitzgerald | 100 ul | 471.6 EUR |
|
Description: Mouse monoclonal HA tag antibody |
|||
 T7 tag Antibody |
|||
| 39276-100ul | SAB | 100ul | 468 EUR |
HA Tag Antibody |
|||
| abx018235-100ug | Abbexa | 100 ug | 460.8 EUR |
 v5 Tag Antibody |
|||
| abx018236-100ug | Abbexa | 100 ug | 410.4 EUR |
v5 Tag Antibody |
|||
| abx018237-100ug | Abbexa | 100 ug | 410.4 EUR |
v5 Tag Antibody |
|||
| abx018238-100ug | Abbexa | 100 ug | 460.8 EUR |
 E Tag Antibody |
|||
| abx018242-100ug | Abbexa | 100 ug | 410.4 EUR |
HA Tag Antibody |
|||
| abx034622-400ul | Abbexa | 400 ul | 627.6 EUR |
HA Tag Antibody |
|||
| abx034622-80l | Abbexa | 80 µl | 343.2 EUR |
HA Tag Antibody |
|||
| abx034628-400ul | Abbexa | 400 ul | 627.6 EUR |
HA Tag Antibody |
|||
| abx034628-80l | Abbexa | 80 µl | 343.2 EUR |
 V5 Tag Antibody |
|||
| abx034630-400ul | Abbexa | 400 ul | 627.6 EUR |
V5 Tag Antibody |
|||
| abx034630-80l | Abbexa | 80 µl | 343.2 EUR |
HA Tag Antibody |
|||
| abx019101-100ug | Abbexa | 100 ug | 385.2 EUR |
S1 tag Antibody |
|||
| abx019163-100ug | Abbexa | 100 ug | 427.2 EUR |
T7 tag Antibody |
|||
| abx019171-100ug | Abbexa | 100 ug | 385.2 EUR |
 V5 tag Antibody |
|||
| abx019189-100ug | Abbexa | 100 ug | 385.2 EUR |
HA Tag Antibody |
|||
| abx037945-100ug | Abbexa | 100 ug | 469.2 EUR |
HA Tag Antibody |
|||
| abx037946-100ug | Abbexa | 100 ug | 469.2 EUR |
HA Tag Antibody |
|||
| 20-abx339070 | Abbexa |
|
|
 V5 tag antibody |
|||
| 70R-12231 | Fitzgerald | 100 ug | 523.2 EUR |
|
Description: Rabbit polyclonal V5 tag antibody |
|||
 S tag antibody |
|||
| 70R-12236 | Fitzgerald | 100 ug | 483.6 EUR |
|
Description: Rabbit polyclonal S tag antibody |
|||
V5 Tag antibody |
|||
| 70R-32858 | Fitzgerald | 100 ug | 301.2 EUR |
|
Description: Goat polyclonal V5 Tag antibody |
|||
HA Tag antibody |
|||
| 70R-36471 | Fitzgerald | 100 ul | 418.8 EUR |
|
Description: Rabbit polyclonal HA Tag antibody |
|||
V5 Tag antibody |
|||
| 70R-36761 | Fitzgerald | 100 ug | 418.8 EUR |
|
Description: Rabbit Polyclonal V5 Tag antibody |
|||
HA Tag antibody |
|||
| 70R-36933 | Fitzgerald | 100 ug | 418.8 EUR |
|
Description: Rabbit Polyclonal HA Tag antibody |
|||
HA tag antibody |
|||
| 70R-51946 | Fitzgerald | 100 ul | 228 EUR |
|
Description: Purified Polyclonal HA tag antibody |
|||